Twist Bioscience Corporation
TWST
$55.95
-$0.26-0.46%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 57.48% | 61.19% | 62.79% | 61.33% | 0.52% |
| Total Depreciation and Amortization | -13.65% | -20.47% | -25.59% | -30.80% | -24.33% |
| Total Amortization of Deferred Charges | 9.68% | 17.24% | 30.77% | 244.44% | 244.44% |
| Total Other Non-Cash Items | -84.76% | -80.94% | -81.80% | -84.78% | 88.96% |
| Change in Net Operating Assets | -845.44% | -366.79% | -181.80% | -139.80% | -87.74% |
| Cash from Operations | 0.94% | 18.44% | 25.69% | 26.40% | 35.14% |
| Capital Expenditure | -320.65% | -511.68% | -451.69% | -221.55% | -4.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -269.33% | 101.74% | -62.99% | 0.07% | -81.85% |
| Cash from Investing | -796.31% | -278.01% | -706.32% | -238.31% | -132.30% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -6.69% | -15.22% | 24.77% | 31.96% | 103.54% |
| Repurchase of Common Stock | 42.31% | 99.23% | 99.60% | 99.57% | 99.57% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -100.00% | -- | -- | -- |
| Cash from Financing | -57.23% | -58.59% | 314.22% | 617.76% | 20,249.26% |
| Foreign Exchange rate Adjustments | -24.60% | 576.74% | 13.49% | 960.00% | 139.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -164.80% | -62.18% | 27.34% | 45.37% | 53.37% |